` Comparison: NVSEF vs BMY - Alpha Spread

NVSEF
vs
BMY

Over the past 12 months, NVSEF has significantly outperformed BMY, delivering a return of +40% compared to the BMY's +0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
NVSEF
BMY
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

NVSEF Intrinsic Value
140.51 USD
Overvaluation 6%
Intrinsic Value
Price
BMY Intrinsic Value
67.99 USD
Undervaluation 13%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Novartis AG
OTC:NVSEF
150 USD
Bristol-Myers Squibb Co
NYSE:BMY
59.43 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
NVSEF, BMY

NVSEF
BMY
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Novartis AG
Revenue
Bristol-Myers Squibb Co
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
NVSEF, BMY

NVSEF
BMY
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Novartis AG
OTC:NVSEF
Bristol-Myers Squibb Co
NYSE:BMY
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

NVSEF
75.8%
BMY
72.6%

Operating Margin

NVSEF
33.2%
BMY
35.8%

Net Margin

NVSEF
24.8%
BMY
14.6%

FCF Margin

NVSEF
27.1%
BMY
26.7%

ROE

NVSEF
31%
BMY
40.5%

ROA

NVSEF
13.1%
BMY
7.7%

ROIC

NVSEF
17.8%
BMY
17%

ROCE

NVSEF
23.8%
BMY
25.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
NVSEF, BMY

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NVSEF, BMY

Loading
NVSEF
BMY
Difference
www.alphaspread.com

Performance By Year
NVSEF, BMY

Loading
NVSEF
BMY
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare NVSEF to other stocks
JNJ
Johnson & Johnson
More expensive
vs NVSEF
ROG
Roche Holding AG
Cheaper
vs NVSEF
MRK
Merck & Co Inc
Cheaper
vs NVSEF
AMGN
Amgen Inc
Cheaper
vs NVSEF
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett